The burden of cognitive impairment
Alzheimer's & Dementia · 2025-08 · 21 (8)
DOI: 10.1002/alz.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 14.08.2025. Verfasst von Tadeja Gracner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Cost of Illness, Alzheimer Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NLM NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
INTRODUCTION Over 10% of older American adults (age ≥ 65) experience cognitive impairment (CI) from Alzheimer's disease and related dementias (ADRD). An additional 15%–22% experience mild cognitive impairment (MCI), often preceding ADRD and in earlier life. However, CI burden estimates including MCI and early‐onset CI (age < 65), remain limited. METHODS Using microsimulation, we estimated CI burden (ADRD and/or MCI) over remaining life‐years for Americans (aged 51/52) who developed CI overall, by disease progression, onset age, and sociodemographic subgroups. Burden equaled the difference in quality‐adjusted life‐years (QALY valued at $150K/year) and economic outcomes between a hypothetical intervention preventing CI and status quo. RESULTS Per capita lifetime CI burden was $124K, driven by lost QALYs. Aggregate CI burden was $627B, 59% from ADRD, 41% from MCI. Early‐onset CI carried the largest per capita burden ($376K), ∼50% from MCI. Individuals with less education, progression to ADRD, or from minoritized racial/ethnic subgroups also carried disproportionate burden. DISCUSSION MCI constitutes 41% of CI burden, disproportionately impacting individuals with early‐onset. Highlights The lifetime burden of cognitive impairment (CI) was estimated at $124,000 per capita, totaling $627 billion in aggregate—with 59% attributed to Alzheimer's disease and related dementias (ADRD) and 41% to mild cognitive impairment (MCI). Early‐onset CI (before age 65) carried the highest per capita burden at $376,000, with these individuals living with MCI for about 13 years—over 7 years longer than those with late‐onset CI. Significant disparities exist in CI burden, with racial/ethnic minorities and those without a high school degree experiencing disproportionately higher burden. Despite representing just 36% of the CI population, non‐White individuals accounted for 47% of the aggregate CI burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA.
- RAND Corporation, Santa Monica, California, USA.
- Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California, USA.
Förderung
- NIA NIH HHS
- NLM NIH HHS
- National Institute on Aging
- U.S. National Library of Medicine
Zitieren
APA
Gracner, T., Chaturvedi, R., Nguyen, P., Heun-Johnson, H., Tysinger, B., Goldman, D., & Lakdawalla, D. (2025). The burden of cognitive impairment. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70436
Vancouver
Gracner T, Chaturvedi R, Nguyen P, Heun-Johnson H, Tysinger B, Goldman D, et al. The burden of cognitive impairment. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70436
BibTeX
@article{Gracner2025,
author = {Gracner, Tadeja and Chaturvedi, Ritika and Nguyen, PhuongGiang and Heun-Johnson, Hanke and Tysinger, Bryan and Goldman, Dana and Lakdawalla, Darius},
title = {The burden of cognitive impairment},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {8},
doi = {10.1002/alz.70436}
}
EUVIMED